Description

Description

Amodip-V 5/160mg is a combination tablet from Mass Pharma that brings together two active ingredients, Amlodipine and Valsartan, in a single once-daily dose. This particular strength offers a higher amount of Valsartan compared to the standard combination, making it suitable for patients whose blood pressure remains elevated despite treatment with lower-dose combination therapy. Amlodipine, a calcium channel blocker, works by relaxing the muscles within blood vessel walls, allowing them to widen and ease the flow of blood. Valsartan, an angiotensin receptor blocker, works differently by blocking the action of a hormone that would otherwise cause blood vessels to constrict. Used together, these two ingredients target blood pressure from complementary angles, often achieving better control than either could provide on its own. Each pack of Amodip-V 5/160mg contains 14 tablets, intended for consistent long-term use as part of a treatment plan overseen by a physician.

Ingredients

Each Amodip-V 5/160mg tablet contains two active pharmaceutical ingredients: Amlodipine at 5mg and Valsartan at 160mg. The tablet formulation also includes standard inactive excipients such as fillers, binding agents, and a film-coating layer, which help maintain the tablet’s physical stability and support easy swallowing, without playing any role in the medicine’s therapeutic action.

Dosage Form

Amodip-V 5/160mg is presented as a film-coated oral tablet, combining 5mg of Amlodipine with 160mg of Valsartan in each unit. The tablets are packaged in blister strips, with 14 tablets supplied per box, intended solely for oral administration.

Uses

Amodip-V 5/160mg is primarily prescribed for managing hypertension in patients who require a stronger dose of Valsartan alongside Amlodipine to achieve adequate blood pressure control. It is often considered for individuals who have not responded sufficiently to the lower-strength combination or to either ingredient used alone. By addressing blood pressure through two distinct physiological pathways, this medication helps reduce the risks associated with long-term uncontrolled hypertension, including stroke, heart attack, and progressive kidney damage. It may form part of a broader treatment approach that also includes lifestyle changes recommended by a healthcare provider.

How to Use

This medication should be taken strictly according to the instructions provided by a prescribing doctor. It is typically taken once a day, at roughly the same time, with or without food. Tablets should be swallowed whole with an adequate amount of water and should not be crushed, split, or chewed unless specifically instructed otherwise by a healthcare professional. Because Amodip-V is used for ongoing blood pressure management, doses should not be missed regularly, and treatment should not be stopped suddenly without first consulting a doctor, even if blood pressure readings appear stable. If a dose is missed, it should be taken as soon as it is remembered, unless the next dose is nearly due, in which case the missed one should be skipped without doubling up.

Side Effects

Since this tablet contains a higher dose of Valsartan, some effects may be more pronounced compared to lower-strength versions, though individual experiences vary. Commonly reported side effects include dizziness, headache, tiredness, and swelling around the ankles or feet. Some patients may experience symptoms of lowered blood pressure, such as lightheadedness when standing up quickly, particularly in the early stages of treatment. Less commonly, side effects such as nausea, muscle or back pain, or elevated potassium levels identified through blood tests may occur. In rare situations, more serious reactions such as severe allergic responses, fainting episodes, or signs of impaired kidney function can develop and warrant immediate medical attention. Any unusual or worsening symptoms should be reported to a healthcare provider without delay.

Pregnancy & Breastfeeding

Amodip-V should not be used during pregnancy without direct medical supervision, as Valsartan-containing medicines are generally not recommended during pregnancy due to the potential for harm to the developing fetus, especially in the second and third trimesters. Breastfeeding mothers should also seek medical advice before taking this medication, as its safety during lactation must be evaluated on an individual basis. Anyone who suspects or confirms pregnancy while on this treatment should contact their doctor right away.

Storage Instructions

Amodip-V tablets should be kept in a cool, dry location, away from direct sunlight and excessive humidity. It is advisable to leave the tablets in their original blister packaging until they are ready to be taken, and to store them safely out of reach of children and pets. Tablets should not be used once the expiry date on the packaging has passed.

FAQs

How is the 5/160mg strength different from the 5/80mg version?
The 5/160mg tablet contains double the amount of Valsartan, and is generally prescribed when the lower-strength combination has not achieved sufficient blood pressure control.

Is this medication suitable as a first treatment for high blood pressure?
It is more commonly prescribed after other treatments, including lower-dose combinations, have proven insufficient, though a doctor will determine the most appropriate starting point for each patient.

Should blood tests be done regularly while taking this medicine?
Yes, periodic monitoring of kidney function and potassium levels is often recommended, particularly at higher Valsartan doses, to ensure the medication remains safe and effective.

Can I stop taking Amodip-V once my blood pressure returns to normal?
No, this medication should not be discontinued without medical advice, as stopping suddenly can cause blood pressure to rise again, even if it has been well controlled during treatment.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.